Kura Oncology to Participate in the 9th European Scientific Oncology Conference
Oct 31, 2016 11:30 am UTC| Business
LA JOLLA, Calif., Oct. 31, 2016 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced its participation in the 9th European Scientific Oncology Conference. Antonio Gualberto,...
Cardtronics Increases ATM Placements in Tops Markets
Oct 31, 2016 11:30 am UTC| Business
HOUSTON, Oct. 31, 2016 -- Cardtronics (Nasdaq:CATM) and Tops Markets have entered into a new agreement that will make Cardtronics the sole non-bank ATM provider to Tops, a leading full-service grocery retailer in the...
KaloBios CEO to Present at the Priority Review Voucher Summit
Oct 31, 2016 11:30 am UTC| Business
BRISBANE, Calif., Oct. 31, 2016 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, MD,...
Spark Therapeutics to Participate in Multiple Upcoming Conferences
Oct 31, 2016 11:30 am UTC| Business
PHILADELPHIA, Oct. 31, 2016 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing investigational,...
Karyopharm to Report Third Quarter 2016 Financial Results on November 7, 2016
Oct 31, 2016 11:30 am UTC| Business
NEWTON, Mass., Oct. 31, 2016 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it will report third quarter 2016 financial results and provide a company update...
Change in number of shares and voting rights in Oasmia Pharmaceutical AB (publ)
Oct 31, 2016 11:25 am UTC| Business
UPPSALA, Sweden, Oct. 31, 2016 -- As of October 31, 2016, the total number of shares and voting rights in Oasmia Pharmaceutical AB (publ) (”Oasmia”) is 119,039,310. Oasmia has, in accordance with previously...
RedHill Biopharma to Present at the BIO-Europe 2016 Conference
Oct 31, 2016 11:00 am UTC| Business
TEL-AVIV, Israel, Oct. 31, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...